PRESTWICK PHARMACEUTICALS INC Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Very truly yours, By: Robert S. Whitehead Chief Executive Officer Prestwick Pharmaceuticals, Inc. (Filed With SEC on April 22, 2005)
- August 4, 2003 Benjamin P. Lewis, Ph.D., R.Ph., RAC24137 Newbury RoadGaithersburg, MD 20882 Re: Offer Letter Dear Ben: (Filed With SEC on April 22, 2005)
- William H. Washecka Date (Filed With SEC on April 22, 2005)
- James P. Shaffer Date (Filed With SEC on April 22, 2005)
- Christopher OBrien, MD Date (Filed With SEC on April 22, 2005)
- Very truly yours, By: Robert S. Whitehead ChiefExecutive Officer (Filed With SEC on April 22, 2005)
- - 1 - (Filed With SEC on April 22, 2005)
- ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 230.406 (Filed With SEC on April 22, 2005)
- Agreement among SCHERING Aktiengesellschaft Mllerstrabe 178 13342 Berlin (hereinafter called SCHERING) and NeuroBiotec GmbH Tegeler Straibe 6 13353 Berlin (hereinafter called... (Filed With SEC on April 22, 2005)
- (1) CAMBRIDGE LABORATORIES LIMITED and (2) PRESTWICK PHARMACEUTICALS, INC., _________________________________________ AMENDED AND RESTATED AGREEMENT... (Filed With SEC on April 22, 2005)
- (1) CAMBRIDGE LABORATORIES LIMITED and (2) PRESTWICK PHARMACEUTICALS, INC., ____________________________________________ AGREEMENT FOR CANADIAN RIGHTS TO NITOMAN... (Filed With SEC on April 22, 2005)